Nycomed extends its Genedata Screener contract
Genedata has signed a multi-year contract extension for the use of the Genedata Screener lead discovery product suite with Nycomed. Under the agreement, Genedata will create a global scientific computing infrastructure for discovery and drug research programs at Nycomed sites worldwide. The number of Genedata Screener users is expected to double under the contract renewal.
Genedata Screener will allow interdisciplinary teams at all of Nycomed’s sites to capture, visualise, analyse and manage large volumes of assay data, independent of instrumentation, technology, volume or location. The effective combination of these findings with data from other corporate sources, accessible through Screener's viewing tools, will provide Nycomed scientists with the range of information they need to enhance their lead finding processes – anywhere on the globe.
Dr Werner Stürmer, Head of HTS at Nycomed, said: ‘Genedata Screener not only improves the efficiency and quality of our screening campaigns, but also has a catalytic impact on our global information network – increasing the number of users and promoting accurate and timely decisions across departments and countries.’